MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis. - Wikidata - wikimedia - TriplyDB

MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.

MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.

http://www.wikidata.org/entity/Q37307396

about

Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.Rs12976445 Polymorphism Is Associated with Post-Ablation Recurrence of Atrial Fibrillation by Modulating the Expression of MicroRNA-125a and Interleukin-6R

P2860

Q38614708-19D1FB4F-BDEB-4DA9-A7DC-C031D3FE1973 Q58749943-85BE7F97-22B5-4ADA-978A-75FCD2955E91

P2860

MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.

http://www.wikidata.org/entity/Q37307396

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@en

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@nl

type

label

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@en

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@nl

prefLabel

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@en

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@nl

P1433

Q37307396-C39D5428-8D8E-47D8-AB80-5AB4438E21F2

P1476

Q37307396-51A20A7F-75F5-4625-B4A2-FDBF77669F84

P2093

Q37307396-105414F9-E10E-4381-8820-D38F0400F607

Q37307396-2D8319EA-06F1-41FC-B1A0-A93B9E783500

Q37307396-30D0729B-6044-435A-BD5E-1FE54FFF907A

Q37307396-56D11D13-F83B-45B6-A549-FC0E2D296B0D

Q37307396-75B54B10-9B99-44C5-99EC-F311200B4C92

Q37307396-BF67A2D8-FE8A-4F50-8FC8-CA18D0DD218E

Q37307396-FABED111-412E-484F-9C25-0198A5D74884

Q37307396-FEF6ED4B-DCE7-47FB-8B0A-FB81A0303152

P2860

Q37307396-08D228A7-963B-454F-AF02-386FD3A6BE67

Q37307396-12F5DC7F-007D-4330-8C94-A5EF4BF1A3C7

Q37307396-1633D172-0FD3-4169-B9E2-0F5DACA82C1B

Q37307396-1F80CBB0-C877-48F9-968F-B03FF19997E1

Q37307396-256C41DB-3CDA-4E44-ACB2-1B0654954992

Q37307396-288EF010-6235-4100-915D-17EB1CCCD831

Q37307396-2C8E7004-586B-467F-AC5E-E0AE402BD71B

Q37307396-30E5872E-4496-43B9-A0C8-8B50BC2C74A3

Q37307396-319888FB-DF8F-4F5D-88A8-26854A9B9837

Q37307396-34861E07-CF5A-4E1E-B5C4-EFBC4DE044BB

P2888

Q37307396-D82837DB-E2F6-4A99-8D7F-E97955A7C728

P304

Q37307396-252B3481-F513-46C8-AEA1-D837A397E204

P31

Q37307396-D730D9D8-83A1-411A-AE39-8F1AAF649D94

P356

Q37307396-6F7167C6-AE1B-478A-AC63-4EA06CB3AFFB

P407

Q37307396-135BEC35-FA4D-4D58-9061-D154060CDC6F

P478

Q37307396-FCD922C3-D9BB-4181-A375-9A24EE4FF361

P50

Q37307396-4D40FD8B-4E74-41AE-A7EE-A368001986F6

P577

Q37307396-CF18EC69-5072-4DEA-979D-FC0D3936227A

P698

Q37307396-D788F6B4-4824-4A01-9328-655581178353

P921

Q37307396-75B77D98-D202-4580-80A6-F26DCFD82B94

Q37307396-D57A635B-D575-42F0-84B6-5E982003475D

P932

Q37307396-D95304A8-B1F9-411B-8A93-7EB5DAC926BD

P356

P1433

Scientific Reports

P1476

MiR-125a-3p timely inhibits ol ...... d in human multiple sclerosis.

@en

P2093

Aida Menéndez Méndez

http://www.w3.org/2001/XMLSchema#string

Annamaria Finardi

http://www.w3.org/2001/XMLSchema#string

Davide Lecca

http://www.w3.org/2001/XMLSchema#string

Davide Marangon

http://www.w3.org/2001/XMLSchema#string

Giusy T Coppolino

http://www.w3.org/2001/XMLSchema#string

Maria P Abbracchio

http://www.w3.org/2001/XMLSchema#string

Roberto Furlan

http://www.w3.org/2001/XMLSchema#string

Vittorio Martinelli

http://www.w3.org/2001/XMLSchema#string

P2860

PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation

MicroRNAs as biomarkers for CNS disease

Cellular and molecular characterization of multipolar Map5-expressing cells: a subset of newly generated, stage-specific parenchymal cells in the mammalian central nervous system

MicroRNAs: genomics, biogenesis, mechanism, and function

The widespread regulation of microRNA biogenesis, function and decay

Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau

The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination

Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination

P2888

P304

34503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP34503

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Gloria Dalla Costa

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698367

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

oligodendrocyte

P932

5048305

http://www.w3.org/2001/XMLSchema#string